Director/PDMR Shareholding

RNS Number : 9828J

MyCelx Technologies Corporation

03 May 2022

 

2 May 2022

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

Dealing by Director

The Company announces that it was notified on 2 May 2022 by Hal Alper, President, Chief Science Officer and a Director of the Company, that on 10 November 2021 he sold 22,500 Common Shares at a price of £0.70 per Common Share. Following this transaction, he continues to be interested in 1,219,546 Common Shares representing 5.31 per cent of the present issued capital of the Company and in 124,339 options over the Company's Common Shares.

For further information please contact:

MYCELX Technologies Corporation Connie Mixon, CEO Kim Slayton, CFO	Tel: [phone]
Canaccord Genuity, Nominated Adviser Henry Fitzgerald-O'Connor Gordon Hamilton	Tel: + 44 20 7523 8000
Celicourt Mark Antelme Jimmy Lea	Tel: [phone]

Notification of transactions of persons discharging managerial responsibility or connected persons

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Hal Alper
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MYCELX Technologies Corporation
b)	LEI	213800UJZINIK2VD1G48
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Common shares of US$0.025 USU624551078
b)	Nature of the transaction	Disposal of Common Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.70 22,500
d)	Aggregated information - Aggregated volume - Price	n/a n/a
e)	Date of the transaction	10/11/2021
f)	Place of the transaction	London Stock Exchange

 

END

 

 

DSHFFFEIELIFIIF